AR010565A1 - Moleculas de acido nucleico aislados, proteina aislada, formulaciones que las contienen, composicion terapeutica, uso de un compuesto protector y uninhibidor para preparar una composicion terapeutica, metodo para producir una proteina de carboxilesterosa, metodo para identificar compuestos, equipo d - Google Patents

Moleculas de acido nucleico aislados, proteina aislada, formulaciones que las contienen, composicion terapeutica, uso de un compuesto protector y uninhibidor para preparar una composicion terapeutica, metodo para producir una proteina de carboxilesterosa, metodo para identificar compuestos, equipo d

Info

Publication number
AR010565A1
AR010565A1 ARP970105237A ARP970105237A AR010565A1 AR 010565 A1 AR010565 A1 AR 010565A1 AR P970105237 A ARP970105237 A AR P970105237A AR P970105237 A ARP970105237 A AR P970105237A AR 010565 A1 AR010565 A1 AR 010565A1
Authority
AR
Argentina
Prior art keywords
composition
protein
nucleic acid
acid molecules
isolated
Prior art date
Application number
ARP970105237A
Other languages
English (en)
Original Assignee
Heska Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heska Corp filed Critical Heska Corp
Publication of AR010565A1 publication Critical patent/AR010565A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Se refiere a las proteínas de esterasa de artropodo; a las moléculas de ácido nucleico de esterasa de artropodo, incluyendo a aquellas que codifican aestas proteínas de esterasa; a los anticuerpos desarrollados contra estas proteínas de esterasa; y a otros compuestos que inhiben a la actividad deesterasa de artropodo. También incluye a los métodos para obtener a estas proteínas; las moléculas de ácido nucleico, anticuerpos y compuestosinhibidores. También están incluidas las composiciones terapéuticas que comprenden a estas proteínas, moléculas de ácido nucleico, anticuerpos y/ocompuestos inhibidores así como también el uso de estas composiciones terapéuticas para proteger a los animales de la infestacion con artropodoshematofagos.
ARP970105237A 1996-11-12 1997-11-11 Moleculas de acido nucleico aislados, proteina aislada, formulaciones que las contienen, composicion terapeutica, uso de un compuesto protector y uninhibidor para preparar una composicion terapeutica, metodo para producir una proteina de carboxilesterosa, metodo para identificar compuestos, equipo d AR010565A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/747,221 US6063610A (en) 1996-11-12 1996-11-12 Carboxylesterase nucleic acid molecules, proteins and uses thereof

Publications (1)

Publication Number Publication Date
AR010565A1 true AR010565A1 (es) 2000-06-28

Family

ID=25004163

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105237A AR010565A1 (es) 1996-11-12 1997-11-11 Moleculas de acido nucleico aislados, proteina aislada, formulaciones que las contienen, composicion terapeutica, uso de un compuesto protector y uninhibidor para preparar una composicion terapeutica, metodo para producir una proteina de carboxilesterosa, metodo para identificar compuestos, equipo d

Country Status (8)

Country Link
US (4) US6063610A (es)
EP (1) EP0942970A1 (es)
JP (1) JP2001506125A (es)
AR (1) AR010565A1 (es)
AU (1) AU5177498A (es)
CA (1) CA2271951A1 (es)
WO (1) WO1998021324A1 (es)
ZA (1) ZA9710163B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063610A (en) * 1996-11-12 2000-05-16 Heska Corporation Carboxylesterase nucleic acid molecules, proteins and uses thereof
US6451992B1 (en) 1998-08-20 2002-09-17 Auburn University Antithrobin nucleotides and proteins from horn fly
AU775084B2 (en) * 1999-04-09 2004-07-15 Heska Corporation Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
EP1710252A3 (en) * 1999-04-09 2006-12-27 Heska Corporation Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
AU2002232644A1 (en) * 2000-12-18 2002-07-01 Millennium Pharmaceuticals, Inc. 53010, a human carboxylesterase family member and uses thereof
EP1543325A4 (en) * 2002-07-17 2008-02-20 Heska Corp OCTOPAMINE RECEPTOR NUCLEIC ACID MOLECULES AND PROTEINS FROM FLOW AND ZECKE AND THEREOF
AU2004258799A1 (en) * 2003-02-21 2005-02-03 Hasumi Llc (Dba Shukokai International) Human lymphocyte vaccine adjuvant
US20050124441A1 (en) * 2003-06-23 2005-06-09 Wound Wood Technologies, Llc Spiral wound laminate wood and method for construction
US8637237B2 (en) * 2003-08-29 2014-01-28 The University Of North Carolina At Greensboro Methods, compositions, and systems for the identification of species-specific or developmental stage-specific insecticides
US7790377B2 (en) * 2003-08-29 2010-09-07 The University Of North Carolina At Greensboro Compounds that act to modulate insect growth and methods and systems for identifying such compounds
US20100240056A1 (en) * 2003-08-29 2010-09-23 Henrich Iii Vincent C Methods And Systems For Screening Species-Specific Insecticidal Candidates
WO2008030858A2 (en) * 2006-09-05 2008-03-13 Integrated Plant Genetics, Inc. Use of esterase expressed in plants for the control of gram-negative bacteria
US9101557B2 (en) 2011-04-13 2015-08-11 Auburn University Combination of protein forms for hornfly vaccination
CN113637657B (zh) * 2021-08-05 2024-01-30 云南师范大学 一种羧酸酯酶CarCB2及其全细胞催化剂和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001909A (en) * 1982-07-14 1991-03-26 Tibbals Jr E C Circular weft knitting machine
US6063610A (en) * 1996-11-12 2000-05-16 Heska Corporation Carboxylesterase nucleic acid molecules, proteins and uses thereof

Also Published As

Publication number Publication date
ZA9710163B (en) 2000-03-13
JP2001506125A (ja) 2001-05-15
US20090170146A1 (en) 2009-07-02
CA2271951A1 (en) 1998-05-22
EP0942970A1 (en) 1999-09-22
US6664090B1 (en) 2003-12-16
US20040081998A1 (en) 2004-04-29
AU5177498A (en) 1998-06-03
WO1998021324A1 (en) 1998-05-22
US6063610A (en) 2000-05-16

Similar Documents

Publication Publication Date Title
BRPI9715334B8 (pt) agentes estrogênicos e composição farmacêutica compreendendo os mesmos.
AR010565A1 (es) Moleculas de acido nucleico aislados, proteina aislada, formulaciones que las contienen, composicion terapeutica, uso de un compuesto protector y uninhibidor para preparar una composicion terapeutica, metodo para producir una proteina de carboxilesterosa, metodo para identificar compuestos, equipo d
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
AR011539A1 (es) DERIVADOS DE BENZOILO-3-HETEROCICLIL-SUSTITUIDOS, PROCEDIMIENTO PARA SU PREPARACIoN,COMPUESTOS INTERMEDIARIOS DE APLICACIoN EN DICHO PROCEDIMIENTO, COMPOSICIONES QUE COMPRENDEN DICHOS DERIVADOS, Y PROCEDIMIENTO PARA SU PREPARACIoN, PROCEDIMIENTO PARA COMBATIR VEGETACIoN NO DESADA QUE LOS EMPLEA Y SU
EA200000298A1 (ru) Агонисты простагландинов и их применение для лечения заболеваний костей
BR9612191A (pt) Inibidores de enzima conversora de interleuciana-1beta
BR0008188A (pt) Inibidores de fator de diferenciação de crescimento e usos para os mesmos
PT966465E (pt) Inibidores do enzima imfdh
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
GT199700074A (es) Derivados de 2-(2-oxo-etiliden)-imidazolidin-4-ona
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
BRPI0414533A (pt) composto, composição farmacêutica, e, métodos para inibir um hsp90 e para tratar um indivìduo tendo um distúrbio mediado por hsp90
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
BR9712085A (pt) Inibidores de metaloprotease heterocìclicos
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
EA199900381A1 (ru) Арил(тио)эфиры галогенпиримидина в качестве пестицидов
BRPI0412659A (pt) isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto
ES2190425T3 (es) Procedimiento para la preparacion de alaninato de (n-fenilacetil-n-2,6-xilil)metilo.
BR0109780A (pt) Soluções de ácido ascórbico estabilizadas; uso das mesmas; processo para sua obtenção e formulações compreendendo as mesmas
BR9916004A (pt) Inibidores de proteinase c de pró-colágeno
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
EA200000165A1 (ru) Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos
EA199900817A1 (ru) Пестицидные 1-арил-3-иминопиразолы
ES2147973T3 (es) Estirenos alquilatados como profarmacos de inhibidores de cox-2.